Spruce Biosciences, Inc. (SPRB)
NASDAQ·Healthcare·Biotechnology
$54.47
-4.75%
Mkt Cap $36.05M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$234.00
Range $160.00 – $283.00
Implied Upside
+329.6%
Consensus $234.00 vs current $54.47
NASDAQ·Healthcare·Biotechnology
$54.47
-4.75%
Mkt Cap $36.05M
No recent rating data.
Price Target (4 analysts)
$234.00
Range $160.00 – $283.00
+329.6%
Consensus $234.00 vs current $54.47